Happy to be here today.
Diversity in clinical research is a critical step on the path
towards HealthEquity.
Our DICT team with the Research Includes ME initiative as our
foundation provided educational resources to patients and
investigator sites, established meaningful connections in our
communities, drove awareness of the clinical trial process and
the trials available and accessible to patients.
Building trust and increasing diversity in clinical trials is
our North Star, moving us closer to our goal of HealthEquity.
I'd like to pass the baton to my colleague, Vipin Kari.
Thank you, Lisa.
Multiple myeloma disproportionately effects Black
people, but clinical trials for this disease are not
representative of the patient population.
Our ORAGA trial aim to change this by selecting sites with
patients from diverse backgrounds and partnering with
groups such as Black Health Matters.
34% of the participants enrolled were people of color, which
exceeded the original goal of 20%.
Our teams are honored to receive this award, as we were to ensure
we have initiatives and trials as diverse as the patients who
need them.